tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Futura Medical Projects Rising Revenues with Eroxon®

Futura Medical Projects Rising Revenues with Eroxon®

Futura Medical (GB:FUM) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Futura Medical PLC, specializing in the development of sexual health products, has announced updated revenue expectations of £13.4 million for 2024 and £18.6 million for 2025, as detailed in a Trinity Delta analyst report. The company’s flagship product, Eroxon®, the only over-the-counter topical gel for erectile dysfunction, is gaining recognition in the market with several industry awards and global distribution partnerships.

For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1